These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Synthesis, pH-dependent, and plasma stability of meropenem prodrugs for potential use against drug-resistant tuberculosis. Teitelbaum AM; Meissner A; Harding RA; Wong CA; Aldrich CC; Remmel RP Bioorg Med Chem; 2013 Sep; 21(17):5605-17. PubMed ID: 23845282 [TBL] [Abstract][Full Text] [Related]
7. Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections. Su FY; Srinivasan S; Lee B; Chen J; Convertine AJ; West TE; Ratner DM; Skerrett SJ; Stayton PS J Control Release; 2018 Oct; 287():1-11. PubMed ID: 30099019 [TBL] [Abstract][Full Text] [Related]
8. Stability of meropenem and doripenem solutions for administration by continuous infusion. Berthoin K; Le Duff CS; Marchand-Brynaert J; Carryn S; Tulkens PM J Antimicrob Chemother; 2010 May; 65(5):1073-5. PubMed ID: 20176578 [No Abstract] [Full Text] [Related]
9. Delivery strategies for sustained drug release in the lungs. Loira-Pastoriza C; Todoroff J; Vanbever R Adv Drug Deliv Rev; 2014 Aug; 75():81-91. PubMed ID: 24915637 [TBL] [Abstract][Full Text] [Related]
10. Polymers and drug delivery systems. Vilar G; Tulla-Puche J; Albericio F Curr Drug Deliv; 2012 Jul; 9(4):367-94. PubMed ID: 22640038 [TBL] [Abstract][Full Text] [Related]
11. High glycolic poly (DL lactic co glycolic acid) nanoparticles for controlled release of meropenem. Nandakumar V; Geetha V; Chittaranjan S; Doble M Biomed Pharmacother; 2013 Jun; 67(5):431-6. PubMed ID: 23583192 [TBL] [Abstract][Full Text] [Related]
12. β-Cyclodextrin complexation as an effective drug delivery system for meropenem. Paczkowska M; Mizera M; Szymanowska-Powałowska D; Lewandowska K; Błaszczak W; Gościańska J; Pietrzak R; Cielecka-Piontek J Eur J Pharm Biopharm; 2016 Feb; 99():24-34. PubMed ID: 26592156 [TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of polymeric pH-sensitive STEALTH® nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel. Lundberg BB Int J Pharm; 2011 Apr; 408(1-2):208-12. PubMed ID: 21296135 [TBL] [Abstract][Full Text] [Related]
14. Design and Evaluation of Hydrophilic Matrix System Containing Polyethylene Oxides for the Zero-Order Controlled Delivery of Water-Insoluble Drugs. Wang L; Chen K; Wen H; Ouyang D; Li X; Gao Y; Pan W; Yang X AAPS PharmSciTech; 2017 Jan; 18(1):82-92. PubMed ID: 26883263 [TBL] [Abstract][Full Text] [Related]
15. Nanoengineered drug delivery systems for enhancing antibiotic therapy. Kalhapure RS; Suleman N; Mocktar C; Seedat N; Govender T J Pharm Sci; 2015 Mar; 104(3):872-905. PubMed ID: 25546108 [TBL] [Abstract][Full Text] [Related]
17. Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs. Kaur R; Garg T; Malik B; Gupta UD; Gupta P; Rath G; Goyal AK Drug Deliv; 2016; 23(3):882-7. PubMed ID: 24870203 [TBL] [Abstract][Full Text] [Related]
18. Formulation and evaluation of controlled release antibiotic biodegradable implants for post operative site delivery. Mathur V; Mudnaik R; Barde L; Roy A; Shivhare U; Bhusari K Acta Pharm; 2010 Mar; 60(1):111-7. PubMed ID: 20228045 [TBL] [Abstract][Full Text] [Related]
19. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. Pandey R; Sharma A; Zahoor A; Sharma S; Khuller GK; Prasad B J Antimicrob Chemother; 2003 Dec; 52(6):981-6. PubMed ID: 14613962 [TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type. Shojaee S; Kaialy W; Cumming KI; Nokhodchi A Pharm Dev Technol; 2016 Mar; 21(2):189-95. PubMed ID: 25410967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]